1. 1. Polaris Observatory HCV Collaborators. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. Lancet Gastroenterol Hepatol 2017;2:161-76.
2. 2. Tozun N, Ozdogan O, Cakaloglu Y, Idilman R, Karasu Z, Akarca U, et al. Seroprevalence of hepatitis B and C virus infections and risk factors in Turkey: a fieldwork TURHEP study. Clin Microbiol Infect 2015;21:1020-6.
3. Association between chronic hepatitis C infection and hepatocellular carcinoma in a Scottish population; Haydon;Gut,1997
4. 4. Kaymakoğlu S, Köksal İ, Kaymakoğlu S, Tabak F, Akarca US, Akbulut A, et al. Recommendation for treatment of hepatitis C virus infection. Turk J Gastroenterol 2017;28(Suppl 2):94-100.
5. Impact of Sustained Virologic Response with Direct-Acting Antiviral Treatment on Mortality in Patients with Advanced Liver Disease; Backus;Hepatology,2019